C

00867

China Medical System Holdings

8.53

-0.18-2.07%
Closed16:08 04/25 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE8.850/8.710
TODAY RANGE8.460-8.880
VOL13.65M
MARKET CAP20.81B
52 WEEK RANGE6.230-10.280
AVG VOL (3M)9.36M
% TURNOVER0.56%
TURNOVER117.39M
P/E (TTM)11.897
% RANGE4.82%
EPS(TTM)0.717
P/E(FORWARD)11.847
P/B1.181
BVPS7.220
DIVIDEND0.291
P/S1.804
BETA--
DIV YIELD3.41%
FREE FLOAT MKT CAP20.81B
SHARES OUTSTANDING2.44B
NEXT EARNINGS08/12-08/17
FREE FLOAT2.44B
LOT SIZE1000
EX-DIV DATE04/28/2025
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

C

China Medical System Holdings

00867

-2.07%
8.530

A

Amgen

04332

--

C

China Conch Venture Holdings

00586

+0.13%
8.010

A

Asymchem Laboratories (Tianjin)

06821

-3.25%
50.650

W

Wuxi Apptec

02359

-1.12%
57.300

S

Sinopharm Group

01099

-0.46%
17.420

G

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

0.00%
16.740

L

Livzon Pharmaceutical Group

01513

-1.11%
26.700

S

Shanghai Pharmaceuticals Holding

02607

0.00%
10.780

S

Shanghai Fosun Pharmaceutical (Group)

02196

+0.27%
14.840

S

SciClone Pharmaceuticals (Holdings)

06600

0.00%
18.720

W

Wuxi Biologics (Cayman)

02269

-0.22%
22.800

C

China Isotope & Radiation

01763

+0.17%
11.520

C

China Shineway Pharmaceutical Group

02877

+0.52%
7.740

T

The United Laboratories International Holdings

03933

-1.29%
13.820

C

Consun Pharmaceutical Group

01681

-1.86%
9.520

3

3SBio

01530

-2.69%
13.020

S

Shandong Xinhua Pharmaceutical

00719

+0.54%
5.630

B

Beijing Tong Ren Tang Chinese Medicine

03613

-1.49%
8.590

C

China Resources Pharmaceutical Group

03320

-0.61%
4.920

C

CSPC Pharmaceutical Group

01093

-0.49%
6.110
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.